Induction of early and bioeffective antibody response in rodents with the luteinizing hormone-releasing hormone vaccine given as a single dose in biodegradable microspheres along with alum

Prostate

Volumn 35, Issue 4, 1998, Pages 279-284

  Diwan, Manish ^a   Dawar, Hema ^a   Talwar, G P ^a  

^a INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY ICGEB   (India)

Author keywords

Controlled release delivery; LHRH DT vaccine; Poly lactide co glycolic acid copolymer; Prostatic atrophy

Indexed keywords

ALUMINUM HYDROXIDE; ALUMINUM POTASSIUM SULFATE; GONADORELIN; MICROSPHERE; POLYGLACTIN; VACCINE;

ADOLESCENT; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; DOSE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

ALUM COMPOUNDS; ANIMALS; ANTIBODY FORMATION; BIODEGRADATION, ENVIRONMENTAL; GONADOTROPIN-RELEASING HORMONE; HUMANS; HYPERPLASIA; MALE; MICROSPHERES; PROSTATE; PROSTATIC HYPERPLASIA; RATS; RATS, WISTAR; VACCINES;

EID: 0032102964     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(19980601)35:4<279::AID-PROS7>3.0.CO;2-B     Document Type: Article

References (15)

1. Jayashankar R, Chaudhari MK, Singh O, Alam A, Talwar GP: Semisynthetic anti-LHRH vaccine causing atrophy of the prostate. Prostate 1989;14:3-11.
2. Rovan E, Fiebiger E, Kalla NR, Talwar GP, Aulitzky W, Frick J: Effect of active immunization to luteinizing-hormone-releasing hormone on the fertility and histoarchitecture of the reproductive organs of male rat. Urol Res 1992;20:323-334.
3. Giri DK, Chaudari MK, Jayashankar R, Neelaram GS, Jayaraman S, Talwar GP: Histopathological changes in reproductive organs of male Wistar rats following active immunization against LHRH. Exp Mol Pathol 1990;52:54-62.
4. Giri DK, Jayaraman S, Neelaram GS, Jayashankar R, Talwar GP: Prostatic hypoplasia in Bonnet monkeys following active immunization with semisynthetic anti-LHRH vaccine. Exp Mol Pathol 1991;54:255-264.
5. Talwar GP, Diwan M, Davar H, Frick J, Sharma SK, Wadhwa SN: Counter GnRH vaccine. In Rajalakshmi M, Griffin PD (eds): "Male Contraception: Present and Future," New Delhi: New Age International 1998:309-318.
6. Visscher GE, Robison RL, Maulding HV, Fong JW, Pearson JE, Argentieri GJ: Biodegradation of and tissue reaction to 50:50 poly(D, L-lactide-co-glycolide) microcapsules. J Biomed Mater Res 1985;20:667.
7. Talwar GP, Chaudhari MK, Jayashankar R: Antigenic derivative of GnRH. UK Patent 2228262, 1992.
8. Chaudhari MK, Talwar GP: Synthesis of muramyl dipeptide derivatives of a decapeptide gonadotropin releasing hormone. J Indian Chem Soc 1989;66:255-257.
9. Elin RJ, Wolff SM, McAdam KPWJ, Chedid I, Audibert F, Bernard C, Oberling F: Properties of reference Eschcrichia coli endotoxin and its phthalylated derivatives in humans. J Infect Dis 1981;144:329-336.
10. Raghuvanshi RS, Misra A, Ganga S, Mehta S, Diwan M, Talwar GP: Antigen loaded microspheres - A strategy for improved immune response. "Proceedings of the 46th Indian Pharmaceutical Congress, 1995 December 28-30; Chandigarh (India)," A-32.
11. Singh M, Li X-M, McGee JP, Zamb T, Koff W, Wang CY, O'Hagan DT: Controlled release microparticles as a single dose hepatitis B vaccine: Evaluation of immunogenicity in mice. Vaccine 1997;15:475-481.
12. Fuerst J, Fiebiger E, Jungwirth A, Mack D, Talwar GP, Frick J, Rovan E: Effect of active immunization against luteinizing hormone-releasing hormone on the androgen-sensitive Dunning R3327-PAP and androgen-independent Dunning R3327-AT2.1 prostate cancer sublines. Prostate 1997;32:77-84.
13. Srkalovic G, Bokser L, Radulovic S, Korkut E, Schally AV: Receptors for luteinizing hormone-releasing hormone in Dunning R3327 prostate cancers and rat anterior pituitaries after treatment with a sustained delivery system of LHRH antagonist SB-75. Endocrinology 1990;127:3052-3060.
14. Gupta RK, Rost BE, Siber GR: Adjuvant properties of aluminum and calcium compounds. In Powell MF, Newman MJ (eds): "Vaccine Design: The Subunit and Adjuvant Approach," New York: Plenum Press, 1995:229-248.
15. Eldridge JH, Staas JK, Meulbroek JA, Tice TR, Gilley RM: Biodegradable and biocompatible poly(D,L-lactide-co-glycolide) microspheres as an adjuvant for staphylococcal enterotoxin B toxoid which enhances the level of toxin-neutralizing activity. Infect Immun 1991;59:2978-2986.